Trial: 201809080

A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy STELLAR Study

Phase

III

Principal Investigator

Chheda, Milan

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov